PD-1/L1 inhibitors can improve but not replace chemotherapy for advanced urothelial carcinoma: A systematic review and network meta-analysis.

Mao, Longkun; Yang, Meihua; Fan, Xinxiang; Li, Wenjie; Huang, Xiaodong; He, Wang; Lin, Tianxin; Huang, Jian

Mao, Longkun; Yang, Meihua; Fan, Xinxiang; Li, Wenjie; Huang, Xiaodong; He, Wang; Lin, Tianxin; Huang, Jian.

Afiliação

Mao L; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Medical Research Center, Sun Yat-Sen Memorial Hospital Sun Yat-Sen (Zhongshan) University Guangzhou China.
Yang M; Department of Urology, Sun Yat-sen Memorial Hospital Sun Yat-sen (Zhongshan) University Guangzhou China.
Fan X; Guangdong Provincial Clinical Research Center for Urological Diseases Guangzhou China.
Li W; Department of Urology, Sun Yat-sen Memorial Hospital Sun Yat-sen (Zhongshan) University Guangzhou China.
Huang X; The First Affiliated Hospital of Nanchang University Nanchang China.
He W; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Medical Research Center, Sun Yat-Sen Memorial Hospital Sun Yat-Sen (Zhongshan) University Guangzhou China.
Lin T; Department of Urology, Sun Yat-sen Memorial Hospital Sun Yat-sen (Zhongshan) University Guangzhou China.
Huang J; Guangdong Provincial Clinical Research Center for Urological Diseases Guangzhou China.

Cancer Innov ; 2(3): 191-202, 2023 Jun.

Article em En | MEDLINE | ID: mdl-38089409

Palavras-chave

chemotherapy; efficacy; immune checkpoint inhibitors; safety; urinary bladder neoplasms

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Systematic_reviews Idioma: En Revista: Cancer Innov Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google